An underground economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.
Investigational Drug Gaining Popularity Via Social Media
The experimental drug, which is still in research studies, is being advertised by social media influencers for its supposed weight-reducing properties. Viewers are urged to contact these profiles directly for source information, while also obtaining promotional offers.
Active Trade on Social Networks
Additionally, a robust trade exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and assertions of next-day British shipping. Vendors market the drug there before redirecting buyers to WhatsApp for transactions.
Understanding The Experimental Drug
This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.
Medical Experts Voice Worries
However, physicians and pharmacists have warned that the distribution of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to users injecting products of unknown origin.
Several experts said the popularity for retatrutide could be linked to the increasing price of approved weight loss products such as Mounjaro.
Regulatory Status and Enforcement
Selling retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Some influencers try to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach pharmaceutical, advertising, and customer laws, risking fines, legal action or prison.
Service Response and Material Elimination
According to the social media company, the platform has taken down problematic material and prohibited associated keywords and search suggestions. The company said it was committed to maintaining the service safe and allocating resources in enhancing enforcement strategies.
Digital Trading Activities
Investigations also discovered groups with up to 9,000 members selling retatrutide using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly brings up groups with thousands of members, populated with photos of slimming results, positive reviews and step-by-step instructions for preparing or administering at residence.
After minutes of entering one community, a vendor posted contact information, where the majority of transactions take place. The seller sent an instruction manual and guaranteed shipping within 48 hours. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about body mass, medical conditions or past usage.
Product Details and Costs
Within these groups, messages display black plastic packages with Royal Mail labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at residence with sterile water, or ready-to-use pens usually priced at 160 pounds for 20 milligrams. When questioned how much time a pen should last, vendors give contradictory responses ranging from a few weeks to “depends on your body”.
Service Moderation and Security Measures
A spokesperson for the messaging service stated it regularly monitored dangerous material on its service including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are administering materials they cannot confirm. Even if the science behind this drug is valid, these online versions may not contain what they claim,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor connected the surge in demand to recent cost increases for approved slimming medications such as Mounjaro. “With costs rising, individuals are using online platforms. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.
Her staff has previously seen patients harmed by personal administration from unverified suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be contaminated or improperly measured.”
Producer Statement
A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company experimental product not yet authorized … may expose users to possibly significant health risks”.
